6% hetastarch in 0.9% sodium chloride

Generic: 6% hetastarch in 0.9% sodium chloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name 6% hetastarch in 0.9% sodium chloride
Generic Name 6% hetastarch in 0.9% sodium chloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

hetastarch 6 g/100mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1317
Product ID 51662-1317_101e9d56-6d64-1bf0-e063-6394a90a22f7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number BA740193
Listing Expiration 2026-12-31
Marketing Start 2018-11-26

Pharmacologic Class

Established (EPC)
plasma volume expander [epc]
Mechanism of Action
osmotic activity [moa]
Chemical Structure
starch [cs]
Physiologic Effect
increased intravascular volume [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621317
Hyphenated Format 51662-1317

Supplemental Identifiers

RxCUI
310757
UNII
875Y4127EA
NUI
N0000184175 N0000009361 N0000010288 M0020435

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name 6% hetastarch in 0.9% sodium chloride (source: ndc)
Generic Name 6% hetastarch in 0.9% sodium chloride (source: ndc)
Application Number BA740193 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 6 g/100mL
source: ndc
Packaging
  • 500 mL in 1 CONTAINER (51662-1317-1)
  • 12 CONTAINER in 1 CASE (51662-1317-3) / 500 mL in 1 CONTAINER (51662-1317-2)
source: ndc

Packages (2)

51662-1317-1 500 mL in 1 CONTAINER (51662-1317-1) 51662-1317-3 12 CONTAINER in 1 CASE (51662-1317-3) / 500 mL in 1 CONTAINER (51662-1317-2)

Ingredients (1)

hetastarch (6 g/100mL)

Linked Drug Pages (1)

6% HETASTARCH IN 0.9% SODIUM CHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "101e9d56-6d64-1bf0-e063-6394a90a22f7", "openfda": {"nui": ["N0000184175", "N0000009361", "N0000010288", "M0020435"], "unii": ["875Y4127EA"], "rxcui": ["310757"], "spl_set_id": ["7b97c681-4514-c544-e053-2991aa0a3d78"], "pharm_class_cs": ["Starch [CS]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]"], "pharm_class_epc": ["Plasma Volume Expander [EPC]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "500 mL in 1 CONTAINER (51662-1317-1)", "package_ndc": "51662-1317-1", "marketing_start_date": "20181126"}, {"sample": false, "description": "12 CONTAINER in 1 CASE (51662-1317-3)  / 500 mL in 1 CONTAINER (51662-1317-2)", "package_ndc": "51662-1317-3", "marketing_start_date": "20181126"}], "brand_name": "6% HETASTARCH IN 0.9% SODIUM CHLORIDE", "product_id": "51662-1317_101e9d56-6d64-1bf0-e063-6394a90a22f7", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Intravascular Volume [PE]", "Osmotic Activity [MoA]", "Plasma Volume Expander [EPC]", "Starch [CS]"], "product_ndc": "51662-1317", "generic_name": "6% HETASTARCH IN 0.9% SODIUM CHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "6% HETASTARCH IN 0.9% SODIUM CHLORIDE", "active_ingredients": [{"name": "HETASTARCH", "strength": "6 g/100mL"}], "application_number": "BA740193", "marketing_category": "ANDA", "marketing_start_date": "20181126", "listing_expiration_date": "20261231"}